Details for Patent: 5,676,962
✉ Email this page to a colleague
Title: | Injectable microfoam containing a sclerosing agent |
Abstract: | Injectable microfoam for scleroteraphy. The sclerotherapy of varices is based on the injection of liquid substances capable of suppressing them. The present invention relates to the preparation of sclerosing substances in the form of a microfoam. The microfoam is prepared with sclerosing agents, and is then injected in the vein to be treated, so that the microfoam displaces the blood contained in the vein and provides for the contact of the sclerosing agent with the vascular endothelium, with a predetermined known concentration and during a controllable time. |
Inventor(s): | Cabrera Garrido; Juan (Granada, ES), Cabrera Garcia-Olmedo; Juan (Granada, ES) |
Assignee: | |
Filing Date: | Feb 23, 1995 |
Application Number: | 08/407,595 |
Claims: | 1. Prepared or extemporaneously prepared injectable microfoam for therapeutic uses characterized in that the microfoam is prepared with any sclerosing substance. 2. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance is polydocanol. 3. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance is sodium tetradecyl sulfate. 4. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance is a hypertonic glucostated or glucosaline solution. 5. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance used is chromated glycerol. 6. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance used is ethanolamine oleate. 7. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance used is sodium morrhuate. 8. Injectable microfoam for therapeutic uses, according to claim 1, characterized in that the sclerosing substance used is any iodated solution. 9. A method for phlebologic treatment comprising injecting the microfoam of claim 1 into vessels to be treated. 10. A method for phlebologic treatment comprising injecting the microfoam of claim 2 into vessels to be treated. 11. A method for phlebologic treatment comprising injecting the microfoam of claim 3 into vessels to be treated. 12. A method for treatment of esophageal varices comprising injecting the microfoam of claim 1 into vessels to be treated. 13. A method for treatment of esophageal varices comprising injecting the microfoam of claim 2 into vessels to be treated. 14. A method for treatment of esophageal varices comprising injecting the microfoam of claim 3 into vessels to be treated. 15. A method for proctologic treatment comprising injecting the microfoam of claim 1 into vessels to be treated. 16. A method for proctologic treatment comprising injecting the microfoam of claim 2 into vessels to be treated. 17. A method for proctologic treatment comprising injecting the microfoam of claim 3 into vessels to be treated. 18. A method for angiologic treatment comprising injecting the microfoam of claim 1 into vessels to be treated. 19. A method for angiologic treatment comprising injecting the microfoam of claim 2 into vessels to be treated. 20. A method for angiologic treatment comprising injecting the microfoam of claim 3 into vessels to be treated. |